CSIMarket
Bridgebio Pharma Inc   (BBIO)
Other Ticker:  
 
 

Bridgebio Pharma Inc 's Yearly Operating Income Growth 5 Years

 

Select the Comparisons : Select the Ratio:



BBIO Annual Operating Income Growth

2022
2021
2020
2019

Y / Y Annual Operating Income Change - - - - -
Annual Operating Income (in millions $) $-512.20 $-576.63 $-474.48 $-266.24 $0.00


Annual Operating Income Growth Comment


Bridgebio Pharma Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Operating Income within Healthcare SectorY/Y Operating Income Growth %2022 Annual Operating Income
Regeneron Pharmaceuticals Inc -47.03 %$ 4,738.900  millions
Tenet Healthcare Corp -18.74 %$ 2,333.000  millions
Biogen Inc   22.63 %$ 3,483.600  millions
Becton Dickinson And Company -18.47 %$ 2,282.000  millions
Vertex Pharmaceuticals Inc  54.83 %$ 4,307.400  millions
Zoetis Inc   5.69 %$ 2,917.000  millions
Stryker Corp  9.95 %$ 2,841.000  millions
Hologic Inc -33.87 %$ 1,640.200  millions
Quest Diagnostics Inc -40.03 %$ 1,428.000  millions
Acadia Healthcare Company Inc   6.92 %$ 2,427.762  millions
Fresenius Medical Care Ag -18.38 %$ 1,693.166  millions
Intuitive Surgical Inc -13.39 %$ 1,577.100  millions
Organon and Co   12.89 %$ 2,041.000  millions
Davita Inc -25.50 %$ 1,339.062  millions
Teva Pharmaceutical Industries Limited